We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$362M
Cap. Flow
-$5M
Cap. Flow %
-0.12%
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$38.3M
2
AMZN icon
Amazon
AMZN
+$27.7M
3
PLTR icon
Palantir
PLTR
+$17.5M
4
HIMS icon
Hims & Hers Health
HIMS
+$13.7M
5
YUMC icon
Yum China
YUMC
+$13.2M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$39.4M
2
NVDA icon
NVIDIA
NVDA
+$30.1M
3
META icon
Meta Platforms (Facebook)
META
+$14.9M
4
BEKE icon
KE Holdings
BEKE
+$14.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 42.45%
2 Consumer Discretionary 16.26%
3 Communication Services 14.17%
4 Healthcare 8.06%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMEA icon
651
Biomea Fusion
BMEA
$86.8M
$1.92K ﹤0.01%
899
+115
+15% +$392
HPE icon
652
Hewlett Packard
HPE
$63.2B
$1.9K ﹤0.01%
+123
New +$2.45K
ARTV
653
Artiva Biotherapeutics
ARTV
$487M
$1.81K ﹤0.01%
603
+93
+18% +$502
TCRX icon
654
TScan Therapeutics
TCRX
$48.6M
$1.68K ﹤0.01%
1,218
+187
+18% +$404
ACRV icon
655
Acrivon Therapeutics
ACRV
$65.9M
$1.57K ﹤0.01%
772
+118
+18% +$635
INZY
656
DELISTED
Inozyme Pharma
INZY
$1.41K ﹤0.01%
1,544
+195
+14% +$270
PYXS icon
657
Pyxis Oncology
PYXS
$168M
$1.4K ﹤0.01%
1,429
+180
+14% +$240
OKUR
658
OnKure Therapeutics
OKUR
$152M
$1.35K ﹤0.01%
313
+47
+18% +$264
STRO icon
659
Sutro Biopharma
STRO
$406M
$1.29K ﹤0.01%
198
+25
+14% +$394
PEPG icon
660
PepGen
PEPG
$121M
$1.14K ﹤0.01%
808
+124
+18% +$255
DELL icon
661
Dell
DELL
$263B
$1K ﹤0.01%
+11
New +$1.16K
MRSN
662
DELISTED
Mersana Therapeutics
MRSN
$893 ﹤0.01%
104
– –
IGMS
663
DELISTED
IGM Biosciences
IGMS
$823 ﹤0.01%
716
– –
TWLO icon
664
Twilio
TWLO
$29.6B
$685 ﹤0.01%
+7
New +$830
QTTB icon
665
Q32 Bio
QTTB
$467M
$436 ﹤0.01%
264
+8
+3% +$22
BBAI icon
666
BigBear.ai
BBAI
$1.32B
$249 ﹤0.01%
+87
New +$414
AAOI icon
667
Applied Optoelectronics
AAOI
$7.71B
– –
-137,500
Closed -$5.07M
AI icon
668
C3.ai
AI
$1.42B
– –
-129,000
Closed -$4.44M
API
669
Agora
API
$338M
– –
-95,000
Closed -$395K
CLDT
670
Chatham Lodging
CLDT
$626M
– –
-882
Closed -$7.89K
IBM icon
671
IBM
IBM
$208B
– –
-1,129
Closed -$248K
LAND
672
Gladstone Land Corp
LAND
$352M
– –
-614
Closed -$6.66K
MSI icon
673
Motorola Solutions
MSI
$72.3B
– –
-273
Closed -$126K
PKST
674
DELISTED
Peakstone Realty Trust
PKST
– –
-656
Closed -$7.26K
PNR icon
675
Pentair
PNR
$10.4B
– –
-3,333
Closed -$335K
24 25 26
27
28

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, GF Fund Management held 683 positions worth $4.26B, down 7.8% from $4.62B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q1 2025 filing shows 46 new, 475 increased, 93 reduced and 17 closed positions. Its largest new stake was Hims & Hers Health: 368,661 shares worth $10.9M. The largest sale was Pinduoduo, an estimated $39.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q1 2025 buy was Hims & Hers Health: 368,661 shares worth $10.9M.
  • GF Fund Management added most to Philip Morris in Q1 2025, an estimated $38.3M increase.
  • GF Fund Management's biggest Q1 2025 reduction was Pinduoduo, cutting an estimated $39.4M.
  • GF Fund Management fully exited Applied Optoelectronics in Q1 2025, selling an estimated $5.07M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.26B portfolio in Q1 2025.
  • GF Fund Management opened 46 new positions and closed 17 in Q1 2025.
  • GF Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.26B.

Based on GF Fund Management's 13F filing for Q1 2025, filed 29 Apr 2025.